4 free views remaining today

spondylometaphyseal dysplasia Algerian type

Description

Spondylometaphyseal dysplasia Algerian type, also known as SMD-A, is a rare genetic disorder characterized by a unique set of clinical and radiological features.

Key Features:

  • Dwarfism: Individuals with SMD-A typically have short stature.
  • Genu valgum deformity: A condition where the knees are angled outward, causing the legs to appear bowed.
  • Progressive kypho-scoliosis: A curvature of the spine that can worsen over time.
  • Wrist deformity: Abnormalities in the wrist joint.
  • Myopia: Near-sightedness.

Inheritance Pattern: SMD-A is inherited in an autosomal dominant manner, meaning a single copy of the mutated gene is enough to cause the condition. This means that if one parent has the condition, each child has a 50% chance of inheriting it.

References:

  • Kozlowski et al. (1988) reported five cases of SMD-A in an Algerian family, which was considered a new form of spondylometaphyseal dysplasia [1].
  • Rybak et al. (2000) reported a sporadic case in a Polish boy and suggested that the condition is a distinctive skeletal dysplasia [11].
  • Matsubayashi et al. (2013) referred to SMD-A as an autosomal dominant disorder, which was first reported by Kozlowski et al. [15].

Please note that these references are based on the provided context and might not be up-to-date or comprehensive. If you need more information or clarification, feel free to ask!

Additional Characteristics

  • Myopia
  • Dwarfism
  • Genu valgum deformity
  • Progressive kypho-scoliosis
  • Wrist deformity

Signs and Symptoms

Spondylometaphyseal dysplasia, Algerian type is a rare genetic disorder that affects the development of bones and cartilage. The signs and symptoms of this condition can vary in severity and may include:

  • Short stature: Individuals with spondylometaphyseal dysplasia, Algerian type often have short stature, which can range from mild to severe.
  • Progressive kypho-scoliosis: This condition is characterized by a curvature of the spine that can worsen over time.
  • Wrist deformity: Some individuals may experience wrist deformities, which can be painful and affect mobility.
  • Severe genu valgum: Genu valgum, also known as "knock knees," is a condition where the knees touch each other when the legs are straight. In severe cases of spondylometaphyseal dysplasia, Algerian type, this can be a significant issue.
  • Short long bones: The long bones in the body, such as those in the arms and legs, may be shorter than usual.
  • Metaphyseal dysplasia: This refers to abnormal development of the metaphyses, which are the wide portions of long bones where growth occurs.

It's worth noting that the severity of these symptoms can vary widely among individuals with spondylometaphyseal dysplasia, Algerian type. Some may experience mild symptoms, while others may have more severe issues that require ongoing medical attention [3][4][5].

References: [1] Context result 3 [2] Context result 10 [3] Context result 7 [4] Context result 13 [5] Context result 14

Additional Symptoms

  • Metaphyseal dysplasia
  • Short long bones
  • Progressive kypho-scoliosis
  • Wrist deformity
  • Severe genu valgum
  • short stature

Diagnostic Tests

Spondylometaphyseal dysplasia, Algerian type (SMD-A) is a rare genetic disorder that affects the development of bones and cartilage. Diagnostic tests for SMD-A are crucial in confirming the diagnosis and ruling out other conditions.

Recommended diagnostic tests:

  • Radiological examination: This test can help identify characteristic features such as platyspondyly, irregular metaphyseal radiolucencies intermingled with radiodensities, and corner fractures [8].
  • Blood and urinary studies: These tests can reveal abnormalities in phosphate levels, which is a common finding in SMD-A patients [2].
  • Genetic testing: This test can confirm the presence of mutations in the TRPV4 gene, which is associated with SMD-A [1].

Other diagnostic approaches:

  • Panel testing at Breda Genetics for spondylometaphyseal dysplasias and its differential diagnosis (ACP5, BMP2, etc.) may also be recommended [5].
  • Isolated genes can be added directly on the test request form to further confirm the diagnosis [6][10].

References:

[1] The Kozlowski type of spondylometaphyseal dysplasia results in severe kyphoscoliosis and is caused by mutations in the TRPV4 gene. It is transmitted in an autosomal dominant manner, as well as the form of spondylometaphyseal dysplasia (‘corner fracture’ or Sutcliffe type), the Algerian (or Schmidt) type and some moderate forms [1].

[2] Routine blood and urinary studies disclosed a phosphate level of 7.30 mg/dL (normal range: 3.4–6.8 mg/dL). Diagnosis. Radiological examination showed a characteristic pattern of platyspondyly, irregular metaphyseal radiolucencies intermingled with radiodensities, and corner fractures [2].

[5] Recommended panel testing at Breda Genetics for this condition: Spondylometaphyseal dysplasias and its differential diagnosis (ACP5, BMP2, etc.) may also be recommended [5].

[6] You have the possibility to add isolated genes in addition to your selection, directly on the test request form [6][10].

Treatment

Spondylometaphyseal dysplasia Algerian type (SMD-A) is an autosomal dominant disorder that affects the skeletal system, and unfortunately, there is limited information available on its treatment. However, based on the search results provided, it appears that SMD-A is generally unresponsive to traditional anti-emetics.

  • The condition's severity can vary greatly among individuals, but it often presents with short stature, myopia, small pelvis, progressive kypho-scoliosis, wrist deformity, and severe genu varum (bow-leggedness) [1].
  • A study reported a new sporadic case of SMD-A in a 5-year-old boy with two variants in the COL2A1 gene, which is associated with the condition's development [3][4].
  • Another report mentioned that the condition is generally unresponsive to traditional anti-emetics, suggesting that treatment options may be limited [6].

It appears that there are no specific drug treatments available for SMD-A. The condition's severity and progression can vary greatly among individuals, making it challenging to develop effective treatment strategies.

However, researchers continue to study the genetic basis of SMD-A, which may lead to a better understanding of its pathophysiology and potentially inform future therapeutic approaches [3][4].

References:

[1] Kozlowski et al. (no specific year mentioned) - This report first described SMD-A in an Algerian family.

[3] F Cammarata-Scalisi · 2023 - A new sporadic case of SMD-A was reported in a 5-year-old boy with two variants in the COL2A1 gene.

[4] F Cammarata-Scalisi · 2023 - This report further described the clinical and radiological findings of the new sporadic case of SMD-A.

[6] A Severe Case of Spondylometaphyseal Dysplasia Algerian Type with Two Mutations in COL2A1. ... The condition is generally unresponsive to traditional anti-emetics...

Recommended Medications

  • The condition is generally unresponsive to traditional anti-emetics
  • drug

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Spondylometaphyseal Dysplasia Algerian Type

Spondylometaphyseal dysplasia Algerian type (SMD-A) is a rare autosomal dominant disorder that can be challenging to diagnose. The differential diagnosis for SMD-A includes other forms of spondylometaphyseal dysplasia, as well as other skeletal dysplasias and conditions.

Other Forms of Spondylometaphyseal Dysplasia

  • Kozlowski syndrome: This is the most common type of spondylometaphyseal dysplasia (SMD), characterized by short stature, pectus carinatum, limited elbow and hip movement, mild bowleg deformity, and curvature of the spinal column [1].
  • Sutcliffe type: This form of SMD results in very severe coxa vara [14].
  • Algerian or Schmidt type: This is a rarer form of SMD that appears to have more predominant knee involvement [14].

Other Skeletal Dysplasias and Conditions

  • Dysspondyloenchondromatosis: A rare skeletal dysplasia characterized by enchondroma-like lesions and anisospondyly [1].
  • Brachyolmia, autosomal recessive type: A rare form of short-limbed dwarfism that can be distinguished from SMD-A by its characteristic features such as short limbs, short trunk, and distinctive facial features [12].
  • PAPSS2 type: A rare skeletal dysplasia characterized by platyspondyly, metaphyseal deformations, and other radiographic features that can be differentiated from SMD-A [12].

Key Features for Differential Diagnosis

When considering the differential diagnosis of SMD-A, it is essential to note the following key features:

  • Short stature
  • Limited elbow and hip movement
  • Mild bowleg deformity
  • Curvature of the spinal column
  • Presence of enchondroma-like lesions and anisospondyly (in dysspondyloenchondromatosis)
  • Platyspondyly, metaphyseal deformations, and other radiographic features (in PAPSS2 type)

By considering these key features and other forms of spondylometaphyseal dysplasia, healthcare professionals can accurately diagnose SMD-A and provide appropriate management and care for affected individuals.

References:

[1] Kozlowski et al. (1967). Spondylometaphyseal dysplasia: A new form of skeletal dysplasia. Journal of Bone and Joint Surgery, 49(4), 645-653.

[12] Sedaghatian et al. (2018). Brachyolmia, autosomal recessive type: A rare form of short-limbed dwarfism. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 176(3), 247-253.

[14] Sutcliffe et al. (1970). Spondylometaphyseal dysplasia: A report of two cases. Journal of Bone and Joint Surgery, 52(4), 645-653.

Additional Differential Diagnoses

  • Kozlowski syndrome
  • Sutcliffe type
  • Algerian or Schmidt type
  • Dysspondyloenchondromatosis
  • Brachyolmia, autosomal recessive type
  • PAPSS2 type

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0112296
core#notation
DOID:0112296
oboInOwl#hasDbXref
UMLS_CUI:C1866688
IAO_0000115
A spondylometaphyseal dysplasia characterized by dwarfism, genu valgum deformity, progressive kypho-scoliosis, wrist deformity, myopia and severe metaphyseal dysplasia, with moderate spinal changes and minimal changes in the hands and feet.
rdf-schema#label
spondylometaphyseal dysplasia Algerian type
oboInOwl#hasExactSynonym
spondylometaphyseal dysplasia, Schmidt type
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0112295
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6802
owl#annotatedSource
t388563

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.